= 8.0) in the placebo group
The participants were all 45 years of age or older and had pre-existing cardiovascular disease, but not diabetes
However, a two-way ANOVA revealed a significant change in GLY levels in the hippocampus between the duration of IF and the diet regimen intervention ( F = 4.965, p = 0.016)
In this study, 422 participants who lost over 5% of initial body weight on a low-calorie diet were randomized to liraglutide 3.0 mg or placebo for 56 weeks
Listen to your body: if you feel fantastic and full of vitality, your plan is likely working and you might stick to it or even lengthen the interval between drips
If maintaining that natural pulse is your priority and you would like to preserve long-term receptor sensitivity, then the shorter-acting peptide variant is right for you, even if it means more frequent injections